Sage Journals: Discover world-class research

Retricted access

Research article

First published 2026

Sacituzumab govitecan in breast cancer patients – an evaluation of progression-free survival,overall survival,and hypersensitivity reactions in real-world patients

Kaitlyn Becker, Christopher Walczak, Jolly Patel

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2025

Capivasertib/Fulvestrant in patients with HR+,HER2-low or HER2-negative locally advanced or metastatic breast cancer

Karam Aboud, Magda Meissner, Rob Jones

Therapeutic Advances in Medical Oncology

Open access

Case report

First published 2021

Hormone Receptor Positive/HER2 Negative Breast Cancer With Isolated Bladder Metastasis: A Rare Case

Noman Ahmed Jang Khan, Mahmoud Abdallah, Maria Tria Tirona

Journal of Investigative Medicine High Impact Case Reports

Retricted access

Research article

First published 2025

Efficacy and safety of phosphoinositide 3-kinase inhibitors and AKT-inhibitors in combination with fulvestrant in PIK3CA mutated,HR-positive,HER2-negative invasive breast cancer: A systematic review

Chris Larck, Joseph B Elmes, R. Wesley Haynes [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2021

Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: subgroup analyses by germline BRCA1 / 2 mutations and hormone receptor status from the phase-3 BROCADE3 trial

Jean-Pierre Ayoub, Hans Wildiers, Michael Friedlander [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2015

Delaying Chemotherapy in the Treatment of Hormone Receptor–Positive,Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

Adam M. Brufsky

Clinical Medicine Insights: Oncology

Free access

Review article

First published 2017-2

Progress with palbociclib in breast cancer: latest evidence and clinical considerations

Andrea Rocca, Alessio Schirone, Roberta Maltoni [...]

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2022-8

Recently approved treatment options for patients with metastatic triple-negative and HER2-neu-positive breast cancer

Sayed Reshad Ghafouri, Suvarna Guvvala, Catherine Jones [...]

Journal of Investigative Medicine

Open access

Case report

First published 2023

CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study

Yuan Yuan, Colt Egelston, Oscar Colunga Flores [...]

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2023-12

Updated Review Article: Cyclin-Dependent Kinase 4/6 Inhibitor Impact,FDA Approval,and Resistance Pathways

Rodney J. Hunter, Jooyoung Park, Kristen J. Asprer [...]

Journal of Pharmacy Technology

Search results